359 related articles for article (PubMed ID: 24937541)
1. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
[TBL] [Abstract][Full Text] [Related]
3. The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia.
Straznicky NE; Lambert EA; Grima MT; Eikelis N; Richards K; Nestel PJ; Dawood T; Masuo K; Sari CI; Dixon JB; Esler MD; Paul E; Schlaich MP; Lambert GW
Obesity (Silver Spring); 2014 Mar; 22(3):652-62. PubMed ID: 23997009
[TBL] [Abstract][Full Text] [Related]
4. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.
Gudbjörnsdottir S; Friberg P; Elam M; Attvall S; Lönnroth P; Wallin BG
Blood Press; 1994 Nov; 3(6):394-403. PubMed ID: 7704288
[TBL] [Abstract][Full Text] [Related]
6. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.
Straznicky NE; Lambert GW; Masuo K; Dawood T; Eikelis N; Nestel PJ; McGrane MT; Mariani JA; Socratous F; Chopra R; Esler MD; Schlaich MP; Lambert EA
Am J Clin Nutr; 2009 Jan; 89(1):27-36. PubMed ID: 19056585
[TBL] [Abstract][Full Text] [Related]
7. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
[TBL] [Abstract][Full Text] [Related]
8. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.
Atuk NO; Hanks JB; Weltman J; Bogdonoff DL; Boyd DG; Vance ML
J Clin Endocrinol Metab; 1994 Dec; 79(6):1609-14. PubMed ID: 7989464
[TBL] [Abstract][Full Text] [Related]
9. Impact of insulin sensitivity treatment with pioglitazone on endothelial function in non-diabetic patients with arterial hypertension.
Schneider F; Vossler S; Franke S; Bär F; Konrad T
Int J Clin Pharmacol Ther; 2009 May; 47(5):311-20. PubMed ID: 19473593
[TBL] [Abstract][Full Text] [Related]
10. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM.
Tack CJ; Smits P; Willemsen JJ; Lenders JW; Thien T; Lutterman JA
Diabetes; 1996 Jan; 45(1):15-22. PubMed ID: 8522054
[TBL] [Abstract][Full Text] [Related]
11. Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome.
Straznicky NE; Grima MT; Lambert EA; Sari CI; Eikelis N; Nestel PJ; Phillips SE; Hering D; Karapanagiotidis S; Dixon JB; Schlaich MP; Lambert GW
J Clin Endocrinol Metab; 2015 Apr; 100(4):1544-50. PubMed ID: 25590214
[TBL] [Abstract][Full Text] [Related]
12. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
[TBL] [Abstract][Full Text] [Related]
13. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids, sympathetic activity, and presynaptic alpha 2-adrenoceptor function in humans.
Lenders JW; Golczynska A; Goldstein DS
J Clin Endocrinol Metab; 1995 Jun; 80(6):1804-8. PubMed ID: 7775627
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone improves left ventricular diastolic function in patients with essential hypertension.
Horio T; Suzuki M; Suzuki K; Takamisawa I; Hiuge A; Kamide K; Takiuchi S; Iwashima Y; Kihara S; Funahashi T; Yoshimasa Y; Kawano Y
Am J Hypertens; 2005 Jul; 18(7):949-57. PubMed ID: 16053992
[TBL] [Abstract][Full Text] [Related]
16. Depressor effect by exercise training is associated with amelioration of hyperinsulinemia and sympathetic overactivity.
Kohno K; Matsuoka H; Takenaka K; Miyake Y; Okuda S; Nomura G; Imaizumi T
Intern Med; 2000 Dec; 39(12):1013-9. PubMed ID: 11197783
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.
Aroda VR; Ciaraldi TP; Burke P; Mudaliar S; Clopton P; Phillips S; Chang RJ; Henry RR
J Clin Endocrinol Metab; 2009 Feb; 94(2):469-76. PubMed ID: 18984667
[TBL] [Abstract][Full Text] [Related]
18. Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects.
Arauz-Pacheco C; Lender D; Snell PG; Huet B; Ramirez LC; Breen L; Mora P; Raskin P
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1172-8. PubMed ID: 8972887
[TBL] [Abstract][Full Text] [Related]
19. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
Vaz M; Jennings G; Turner A; Cox H; Lambert G; Esler M
Circulation; 1997 Nov; 96(10):3423-9. PubMed ID: 9396437
[TBL] [Abstract][Full Text] [Related]
20. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
